TAXOTERE (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the TAXOTERE drug offered from sanofi-aventis U.S. LLC. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
| NON-PROPRIETARY NAME: | Docetaxel |
| SUBSTANCE NAME: | DOCETAXEL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-08-02 |
| END MARKETING DATE: | 0000-00-00 |
TAXOTERE HUMAN PRESCRIPTION DRUG Details:
| Item Description | TAXOTERE from sanofi-aventis U.S. LLC |
| LABELER NAME: | sanofi-aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2010-08-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0075-8003_ac6265cf-4409-4e1f-a8b0-cf178c767617 |
| PRODUCT NDC: | 0075-8003 |
| APPLICATION NUMBER: | NDA020449 |
Other DOCETAXEL Pharmaceutical Manufacturers / Labelers:
